ACXP (Acurx) שולי רווח גולמי

ACXP (Acurx Pharmaceuticals, Inc.) - סמל מסחרי של החברה

Despite the narrow specialization of current phase II clinical trials, Acurx Pharmaceuticals (ACXP) relies on stable demand in the hospital sector, which ensures high profitability. The gross margin trend on the GURU.Markets website demonstrates cost efficiency, where the 0.00 level reflects the current value of the metric. The ACXP strategy is based on creating selective gut antibiotics, which minimizes risks by protecting beneficial microflora.

Acurx Pharmaceuticals, Inc. (ACXP): רווחיות לפי רווח גולמי מ-04.07.2022 עד 20.11.2026

פילוחי מדדים מקיפים ואנליטיקה עבור Acurx Pharmaceuticals (ACXP)

- ציטוטים נוכחיים ותחזית שווי ממוצעת:
- מדדי הערכת שווי שוק של העסק:
ניתוח מסכם של החברה:acurxpharma.com (ACXP)
מוצרים מיוצרים של Acurx

Identifying assets with a high margin of safety requires an analysis of profit generation efficiency. Gross margin measures the portion of revenue remaining after covering direct production costs, allowing for an assessment of operating profitability and resilience to external shocks. By utilizing external CMO facilities, Acurx Pharmaceuticals (ACXP) minimizes capital expenditures, which is directly reflected in the current gross margin trend.